May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Recurrent Polypoidal Choroidal Vasculopathy After Long-Term Follow-Up of Photodynamic Therapy With Verteporfin
Author Affiliations & Notes
  • M. Yamamoto
    Ophthalmology & Visual Science, Osaka City Univ Medical School, Osaka-Shi, Japan
  • T. Kohno
    Ophthalmology & Visual Science, Osaka City Univ Medical School, Osaka-Shi, Japan
  • K. Shiraki
    Ophthalmology & Visual Science, Osaka City Univ Medical School, Osaka-Shi, Japan
  • N. Miki
    Ophthalmology & Visual Science, Osaka City Univ Medical School, Osaka-Shi, Japan
  • Y. Nomura
    Ophthalmology & Visual Science, Osaka City Univ Medical School, Osaka-Shi, Japan
  • M. Kaida
    Ophthalmology & Visual Science, Osaka City Univ Medical School, Osaka-Shi, Japan
  • S. Ataka
    Ophthalmology & Visual Science, Osaka City Univ Medical School, Osaka-Shi, Japan
  • M. Hirabayashi
    Higashi Ikoma Hospital, Osaka-Shi, Japan
  • Footnotes
    Commercial Relationships  M. Yamamoto, None; T. Kohno, None; K. Shiraki, None; N. Miki, None; Y. Nomura, None; M. Kaida, None; S. Ataka, None; M. Hirabayashi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 570. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Yamamoto, T. Kohno, K. Shiraki, N. Miki, Y. Nomura, M. Kaida, S. Ataka, M. Hirabayashi; Recurrent Polypoidal Choroidal Vasculopathy After Long-Term Follow-Up of Photodynamic Therapy With Verteporfin. Invest. Ophthalmol. Vis. Sci. 2008;49(13):570.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the recurrent cases of polypoidal choroidal vasculopathy (PCV) after photodynamic therapy (PDT) with verteporfin.

Methods: : Forty-five eyes of forty-four consecutive patients with PCV, whose polyps had disappeared after the first PDT and who had completed at least one-year follow-up, were studied retrospectively. PDT retreatment was performed when polypoidal lesions recurred and leakage was seen on fluorescein (FA) and indocyanine green angiograms (IA). The recurrence rates and the recurrence regions were studied, and the mean logMAR best corrected visual acuity (BCVA) changes from baseline were compared between the recurrence and the non-recurrence group.

Results: : The mean follow-up period was 23.4 months. Polypoidal lesions recurred in 12 eyes of 45 eyes (26.7%) at one-year follow-up, 10 eyes of 30 eyes (33.3%) at two-year follow-up, 6 eyes of 9 eyes (66.7%) at 3 year follow-up. Throughout all the follow-up periods, polypoidal lesion recurred in 18 eyes (40.0%) in the average of 14.0 months. The recurrence regions were at the same sites as the pre-operative regions in 6 eyes, within the abnormal vascular networks in 5 eyes and around the abnormal vascular networks in 7 eyes. Mean log MAR BCVA changes showed an improvement of 1.4 and 2.6 lines in the recurrence group and the non-recurrence group, respectively (p=0.16, Mann-Whitney’s U-test).

Conclusions: : PCV recurred at a high probability for the long-term follow-up even when polypoidal lesions disappeared completely after PDT. Continuing follow-up examinations and periodic FA and IA are recommended.

Keywords: age-related macular degeneration • photodynamic therapy • choroid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×